Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risperidone side effects.

R R Conley1

  • 1Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore 21228, USA.

The Journal of Clinical Psychiatry
|May 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of the special patient with schizophrenia.

Dialogues in clinical neuroscience·2011
Same author

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.

The pharmacogenomics journal·2009
Same author

ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.

Molecular psychiatry·2005
Same author

Assessment of capacity to give consent to research participation: state-of-the-art and beyond.

Journal of health care law & policy·2004
Same author

Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement.

Human psychopharmacology·2003
Same author

Management of treatment resistance in schizophrenia.

Biological psychiatry·2001
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Risperidone, an atypical antipsychotic, shows fewer motor side effects and less weight gain than traditional antipsychotics. Clinicians should monitor for adverse events, including elevated prolactin levels, in patients on risperidone.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Traditional antipsychotics for schizophrenia cause extrapyramidal side effects, leading to poor adherence.
  • Atypical antipsychotics offer an alternative, but data on their adverse events are limited.

Purpose of the Study:

  • To review the adverse event profile of risperidone, a combined 5-HT2/D2 antagonist.
  • To compare risperidone's side effects with those of traditional antipsychotics and other atypical agents.

Main Methods:

  • Literature review focusing on adverse events associated with risperidone.
  • Comparison of side effect profiles across different antipsychotic classes.

Main Results:

  • Risperidone is associated with minimal motor side effects compared to traditional antipsychotics.

Related Experiment Videos

  • Weight gain is less common with risperidone than with clozapine or olanzapine.
  • Increased prolactin levels are reported but show little correlation with adverse events.
  • Conclusions:

    • Risperidone presents a favorable side effect profile regarding motor symptoms and weight gain.
    • Clinicians must remain vigilant for potential adverse events, including hyperprolactinemia, with atypical antipsychotics like risperidone.